News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Jeffrey S. Miller, MD

Articles by Jeffrey S. Miller, MD

Jeffrey S. Miller, MD, professor, medicine, Division of Hematology, Oncology and Transplantation; deputy director; Roger L. and Lynn C. Headrick Chair in Cancer Therapeutics; associate scientific director, Molecular and Cellular Therapeutics, University of Minnesota Masonic Cancer Center

Dr Miller on the Use of NK Cell Therapy in Hematologic Malignancies

ByJeffrey S. Miller, MD

August 16th 2024

Jeffrey S. Miller, MD, discusses research with natural killer cell therapy in patients with hematologic malignancies and other cancers.

Latest Updated Articles

Trending on OncLive

Sacituzumab Govitecan Approved in Europe for First-Line PD-L1 Inhibitor–Ineligible TNBC

Sigvotatug Vedotin Fails to Improve OS in Advanced, Pretreated Nonsquamous NSCLC

Venetoclax/Ibrutinib Clears Resistance Mutations in BTK Inhibitor–Resistant CLL

NCCN Includes PCR ctDNA-MRD Testing in MIBC Treatment Algorithm

Allogeneic BCMA CAR T-Cell Therapy CT0596 Elicits 100% ORR in R/R Myeloma and Plasma Cell Leukemia